T2 Biosystems, Inc.
TTOO
$0.106
-$0.004-3.64%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -42.95M | -48.26M | -45.65M | -50.08M | -49.84M |
| Total Depreciation and Amortization | 259.00K | 462.00K | 667.00K | 859.00K | 1.04M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 682.00K | 682.00K |
| Total Other Non-Cash Items | 3.65M | 8.08M | 2.07M | 4.44M | 4.21M |
| Change in Net Operating Assets | 2.45M | -4.01M | -3.97M | -4.04M | -5.15M |
| Cash from Operations | -36.59M | -43.73M | -46.88M | -48.14M | -49.05M |
| Capital Expenditure | -26.00K | -39.00K | -72.00K | -192.00K | -202.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -26.00K | -39.00K | -72.00K | -192.00K | -202.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.38M | 32.00M | 43.11M | 52.75M | 53.02M |
| Repurchase of Common Stock | -1.00K | -1.00K | -1.00K | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -330.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -62.00K | -62.00K | -62.00K | -62.00K |
| Cash from Financing | 14.38M | 31.93M | 43.04M | 52.69M | 52.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.24M | -11.84M | -3.91M | 4.36M | 3.37M |